These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7911341)

  • 1. Flow cytometry of blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells and lymphocyte subsets after treatment with 2-chlorodeoxyadenosine.
    Juliusson G; Lenkei R; Liliemark J
    Blood; 1994 Jun; 83(12):3672-81. PubMed ID: 7911341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment.
    Babuŝíková O; Tomová A; Kusenda J; Gyárfás J
    Neoplasma; 2001; 48(5):350-7. PubMed ID: 11845978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-lasting decrease of CD4+/CD45RA+ T cells in HCL patients after 2-chlorodeoxyadenosine (2-CdA) treatment.
    Raspadori D; Rondelli D; Birtolo S; Lenoci M; Nardi G; Scalia G; Sestigiani C; Tozzi M; Marotta G; Lauria F
    Leukemia; 1999 Aug; 13(8):1254-7. PubMed ID: 10450754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimal residual disease in hairy-cell leukemia after treatment with 2-chlorodeoxyadenosine.
    Konwalinka G; Schirmer M; Hilbe W; Fend F; Geisen F; Knoblechner A; Petzer A; Thaler J
    Blood Cells Mol Dis; 1995; 21(2):142-51. PubMed ID: 8846043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-chlorodeoxyadenosine induces durable remissions and prolonged suppression of CD4+ lymphocyte counts in patients with hairy cell leukemia.
    Seymour JF; Kurzrock R; Freireich EJ; Estey EH
    Blood; 1994 May; 83(10):2906-11. PubMed ID: 7910051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of minimal residual disease by immunostaining of bone marrow biopsies after 2-chlorodeoxyadenosine for hairy cell leukemia.
    Hakimian D; Tallman MS; Kiley C; Peterson L
    Blood; 1993 Sep; 82(6):1798-802. PubMed ID: 7691237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reference values for peripheral blood lymphocyte phenotypes applicable to the healthy adult population in Switzerland.
    Bisset LR; Lung TL; Kaelin M; Ludwig E; Dubs RW
    Eur J Haematol; 2004 Mar; 72(3):203-12. PubMed ID: 14962239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response duration and recovery of CD4+ lymphocytes following deoxycoformycin in interferon-alpha-resistant hairy cell leukemia: 7-year follow-up.
    Seymour JF; Talpaz M; Kurzrock R
    Leukemia; 1997 Jan; 11(1):42-7. PubMed ID: 9001417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid restoration of natural killer activity following treatment with 2-chlorodeoxyadenosine in 22 patients with hairy-cell leukemia.
    Lauria F; Rondelli D; Raspadori D; Benfenati D; Tura S
    Eur J Haematol; 1994 Jan; 52(1):16-20. PubMed ID: 7905425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cells and natural killer cells after treatment of hairy cell leukaemia with 2-chlorodeoxyadenosine.
    Schirmer M; Hilbe W; Geisen F; Thaler J; Konwalinka G
    Acta Haematol; 1997; 97(3):180-3. PubMed ID: 9066714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five years follow-up after 2-chloro deoxyadenosine treatment in thirty patients with hairy cell leukemia: evaluation of minimal residual disease and CD4+ lymphocytopenia after treatment.
    Bastie JN; Cazals-Hatem D; Daniel MT; D'Agay MF; Rabian C; Glaisner S; Noel-Walter MP; Dabout D; Flandrin G; Dombret H; Poisson D; Degos L; Castaigne S
    Leuk Lymphoma; 1999 Nov; 35(5-6):555-65. PubMed ID: 10609793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up of patients with hairy cell leukaemia treated with pentostatin: lymphocyte subpopulations and residual bone marrow infiltration.
    Thaler J; Grünewald K; Gattringer C; Ho AD; Weyrer K; Dietze O; Stauder R; Fluckinger T; Lang A; Huber H
    Br J Haematol; 1993 May; 84(1):75-82. PubMed ID: 8338781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistological assessment of bone marrow biopsies from patients with hairy cell leukemia: changes following treatment with alpha-2-interferon and deoxycoformycin.
    Thaler J; Denz H; Dietze O; Gastl G; Ho AD; Gattringer C; Greil R; Lechleitner M; Huber C; Huber H
    Leuk Res; 1989; 13(5):377-83. PubMed ID: 2787447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia and hairy cell leukemia variant: 7-year experience in Poland.
    Robak T; Błasińska-Morawiec M; Błoński J; Hellmann A; Hałaburda K; Konopka L; Kotlarek-Haus S; Potoczek S; Hansz J; Dmoszyńska A; Urasiński I; Zdziarska B; Dwilewicz-Trojaczek J; Hołowiecki J; Skotnicki AB
    Eur J Haematol; 1999 Jan; 62(1):49-56. PubMed ID: 9918312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ex vivo evidence of lymphocyte apoptosis in hairy cell leukemia, induced by 2-chlorodeoxyadenosine treatment.
    Idink-Mecking CA; Richel DJ; Vermes I; Schaafsma MR; Reutelingsperger C; Haanen C
    Ann Hematol; 1998 Jan; 76(1):25-9. PubMed ID: 9486921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to interferon-alpha in patients with hairy cell leukemia relapsing after treatment with 2-chlorodeoxyadenosine.
    Seymour JF; Estey EH; Keating MJ; Kurzrock R
    Leukemia; 1995 May; 9(5):929-32. PubMed ID: 7769859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcutaneous injections of 2-chlorodeoxyadenosine for symptomatic hairy cell leukemia.
    Juliusson G; Heldal D; Hippe E; Hedenus M; Malm C; Wallman K; Stolt CM; Evensen SA; Albertioni F; Tjønnfjord G
    J Clin Oncol; 1995 Apr; 13(4):989-95. PubMed ID: 7707128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotype of lymphocyte subsets after autologous peripheral blood stem cell transplantation.
    Koehne G; Zeller W; Stockschlaeder M; Zander AR
    Bone Marrow Transplant; 1997 Jan; 19(2):149-56. PubMed ID: 9116612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormalities in the T and NK lymphocyte phenotype in patients with Nijmegen breakage syndrome.
    Michałkiewicz J; Barth C; Chrzanowska K; Gregorek H; Syczewska M; Weemaes CM; Madaliński K; Stachowski J;
    Clin Exp Immunol; 2003 Dec; 134(3):482-90. PubMed ID: 14632755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.